AAAAAA

   
Results: 1-25 | 26-37 |
Results: 26-37/37
Effects of glucosamine infusion on insulin secretion and insulin action inhumans
Authors: Monauni, T Zenti, MG Cretti, A Daniels, MC Targher, G Caruso, B Caputo, M McClain, D Del Prato, S Giaccari, A Muggeo, M Bonora, E Bonadonna, RC
Citation: T. Monauni et al., Effects of glucosamine infusion on insulin secretion and insulin action inhumans, DIABETES, 49(6), 2000, pp. 926-935
Predictors of cardiovascular mortality in type 2 diabetes background
Authors: Muggeo, M
Citation: M. Muggeo, Predictors of cardiovascular mortality in type 2 diabetes background, DIABETES IN THE NEW MILLENNIUM, 2000, pp. 247-256
Attending the diabetes center is associated with reduced cardiovascular mortality in type 2 diabetic patients: the Verona Diabetes Study
Authors: Zoppini, G Verlato, G Bonora, E Muggeo, M
Citation: G. Zoppini et al., Attending the diabetes center is associated with reduced cardiovascular mortality in type 2 diabetic patients: the Verona Diabetes Study, DIABET M R, 15(3), 1999, pp. 170-174
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria
Authors: Arcaro, G Zenere, BM Saggiani, F Zenti, MG Monauni, T Lechi, A Muggeo, M Bonadonna, RC
Citation: G. Arcaro et al., ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria, DIABET CARE, 22(9), 1999, pp. 1536-1542
Plasma glucose within the normal range is not associated with carotid atherosclerosis - Prospective results in subjects with normal glucose tolerancefrom the Bruneck Study
Authors: Bonora, E Kiechl, S Willeit, J Oberhollenzer, F Egger, G Bonadonna, R Muggeo, M
Citation: E. Bonora et al., Plasma glucose within the normal range is not associated with carotid atherosclerosis - Prospective results in subjects with normal glucose tolerancefrom the Bruneck Study, DIABET CARE, 22(8), 1999, pp. 1339-1346
Cause-specific mortality in type 2 diabetes - The Verona Diabetes Study
Authors: de Marco, R Locatelli, F Zoppini, G Verlato, G Bonora, E Muggeo, M
Citation: R. De Marco et al., Cause-specific mortality in type 2 diabetes - The Verona Diabetes Study, DIABET CARE, 22(5), 1999, pp. 756-761
Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients
Authors: Zoppini, G Targher, G Cacciatori, V Guerriero, A Muggeo, M
Citation: G. Zoppini et al., Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients, DIABET CARE, 22(11), 1999, pp. 1871-1874
Effect of chronic treatment with lacidipine or lisinopril on intracellularpartitioning of glucose metabolism in type 2 diabetes mellitus
Authors: Bonora, E Targher, G Alberiche, M Bonadonna, RC Saggiani, F Zenere, MB Uleri, S Muggeo, M
Citation: E. Bonora et al., Effect of chronic treatment with lacidipine or lisinopril on intracellularpartitioning of glucose metabolism in type 2 diabetes mellitus, J CLIN END, 84(5), 1999, pp. 1544-1550
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist
Authors: Moghetti, P Castello, R Zamberlan, N Rossini, M Gatti, D Negri, C Tosi, F Muggeo, M Adami, S
Citation: P. Moghetti et al., Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist, J CLIN END, 84(4), 1999, pp. 1250-1254
Authors' response: Spironolactone but not flutamide administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist
Authors: Moghetti, P Castello, R Zamberlan, N Rossini, M Gatti, D Negri, C Tosi, F Muggeo, M Adami, S
Citation: P. Moghetti et al., Authors' response: Spironolactone but not flutamide administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist, J CLIN END, 84(12), 1999, pp. 4747-4747
Accelerated complications in Type 2 diabetes mellitus: The need for greater awareness and earlier detection
Authors: Muggeo, M
Citation: M. Muggeo, Accelerated complications in Type 2 diabetes mellitus: The need for greater awareness and earlier detection, DIABET MED, 15(12), 1998, pp. S60-S62
Accelerated complications in Type 2 diabetes mellitus: The need for greater awareness and earlier detection
Authors: Muggeo, M
Citation: M. Muggeo, Accelerated complications in Type 2 diabetes mellitus: The need for greater awareness and earlier detection, DIABET MED, 15(12), 1998, pp. S60-S62
Risultati: 1-25 | 26-37 |